Short-term efficacy of microwave ablation in the treatment of liver cancer and its effect on immune function

Table 5 Comparison of immune function indexes between the two groups, mean ± SD

Immune function indicators	Stage	Liver cancer resection group (n = 35)	Liver cancer ablation group (n = 35)	t	P value
CD4+ (%)	Before treatment	29.75 ± 6.32	29.52 ± 6.43	0.151	0.880
	After one month of treatment	35.27 ± 5.56a	43.95 ± 5.72a	6.437	< 0.001
CD8+ (%)	Before treatment	25.09 ± 4.78	25.43 ± 4.96	0.292	0.771
	After one month of treatment	22.75 ± 4.62a	20.38 ± 3.91a	2.317	0.024
CD4+/CD8+	Before treatment	1.19 ± 0.28	1.16 ± 0.25	0.473	0.638
	After one month of treatment	1.55 ± 0.32a	2.16 ± 0.39a	7.154	< 0.001

^aP < 0.05 vs before treatment.